J. Goldman & Co’s Teladoc Health TDOC Stock Holding History

J. Goldman & Co’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$664K	–	353
2019 Q2	$664K	Buy	+10,000	New	+$583K	0.05%	211

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

J. Goldman & Co's TDOC Position: Q3 2025 in Review

J. Goldman & Co sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 437,413 shares — an estimated $3.81M sold.

J. Goldman & Co first reported a position in TDOC in Q2 2025 and held it in 1 quarter. The position peaked at $3.81M in Q2 2025. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

J. Goldman & Co reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
J. Goldman & Co sold 437,413 Teladoc Health shares in Q3 2025, an estimated $3.81M.
J. Goldman & Co first reported a position in Teladoc Health in Q2 2025 and held it in 1 quarter.
J. Goldman & Co's Teladoc Health position peaked at $3.81M in Q2 2025.
355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.